Dr. Jean Michel Bolla is a distinguished researcher specializing in microbiology, biochemistry, and antibiotic resistance. With over 30 years of experience, he has made significant contributions to understanding bacterial resistance mechanisms, particularly efflux-mediated resistance in Gram-negative bacteria. As the Director of Research at Inserm U-1261, he has led pioneering studies in bacterial physiology and virulence, as well as the development of screening platforms for antibiotic-resistant bacteria. His leadership in the Bac-Screen platform, which enables high-throughput screening of antimicrobial compounds, highlights his commitment to innovative research. Dr. Bolla has supervised multiple PhD students and postdoctoral researchers, securing major research funding from national and international agencies. His work has been recognized through invited talks at international conferences and a patent related to diagnostic tools for antibiotic resistance. Additionally, he has contributed significantly to academia through teaching roles at Aix-Marseille Université and Université de Corse. His research continues to shape the field of antimicrobial resistance, addressing one of the most pressing global health challenges. Through his expertise, leadership, and dedication to scientific advancement, Dr. Bolla has established himself as a leading figure in microbiology and antibiotic resistance research.

Professional Profile

Education

Dr. Jean Michel Bolla holds a PhD in Biochemistry and Molecular Biology from UPR9027 CNRS, Marseille, awarded in 1990. His doctoral research focused on protein export and assembly in Escherichia coli, conducted under the supervision of Dr. JM Pagès. Following his PhD, he pursued a postdoctoral fellowship at Inserm-APHP, Paris, where he worked on iron starvation responses in Listeria monocytogenes under Dr. P. Berche. His advanced training includes specialization in Campylobacter porins at the Laboratory Centre for Disease Control in Ottawa and Winnipeg, Canada in 1997 and 1998. In 2001, he obtained his Habilitation à Diriger des Recherches (HDR) from the Faculty of Medicine, Timone, Marseille, enabling him to supervise doctoral research. His extensive academic training has provided him with a strong foundation in molecular microbiology, biochemistry, and antibiotic resistance. Through continuous education and research, Dr. Bolla has developed a deep understanding of bacterial physiology, antimicrobial resistance mechanisms, and drug discovery. His educational background has been instrumental in shaping his career as a leading researcher in microbiology and antibiotic resistance, allowing him to contribute groundbreaking insights to the field.

Professional Experience

Dr. Jean Michel Bolla has had an illustrious career in research, spanning over three decades. He began as a postdoctoral researcher at Inserm-APHP, Paris, before joining Inserm as a Chargé de Recherche in 1992. Over the years, he advanced within Inserm, holding key research positions, and became Director of Research at U-1261 in 2018. He has led major research initiatives, including the establishment of the Bac-Screen platform, a high-throughput screening system for antibiotic resistance studies. From 2007 to 2011, he also served as an Associate Professor at the Université de Corse, where he contributed significantly to teaching and student mentorship. Throughout his career, Dr. Bolla has supervised seven PhD students and three postdoctoral researchers, demonstrating his commitment to training future scientists. He has been an invited speaker at multiple international conferences, sharing his expertise in antibiotic resistance. His ability to secure major research funding, including grants from CNRS, ANR, and FEAMPA, underscores his impact in the field. His leadership roles at Inserm and collaborations with various research institutions have solidified his reputation as an expert in microbiology and antibiotic resistance.

Research Interest

Dr. Jean Michel Bolla’s research primarily focuses on antibiotic resistance mechanisms, with a particular emphasis on efflux-mediated resistance in Gram-negative bacteria. His work explores the physiology and virulence of bacterial pathogens, including Campylobacter jejuni and Listeria monocytogenes. He is deeply involved in drug discovery and screening technologies, having developed the Bac-Screen platform to identify novel antimicrobial compounds and assess their mechanisms of action. His research also extends to bacterial membrane permeability, studying how bacterial outer membrane porins influence antibiotic uptake and resistance. More recently, he has been engaged in synthetic antibacterial polymer development for therapeutic applications. His work contributes to understanding multidrug resistance mechanisms, a major global health challenge, and seeks innovative solutions to combat bacterial infections. Additionally, he collaborates on projects involving diagnostic tools for detecting antimicrobial resistance, aiming to improve early detection and treatment strategies. Through his research, Dr. Bolla strives to bridge the gap between basic microbiology and clinical applications, working towards the development of effective antimicrobial strategies to tackle the increasing threat of drug-resistant bacteria worldwide.

Research Skills

Dr. Jean Michel Bolla possesses a diverse range of research skills, with expertise in molecular microbiology, biochemistry, and antimicrobial resistance. He has extensive experience in protein purification, bacterial physiology studies, and genetic manipulation of bacterial pathogens. His work in high-throughput screening techniques has been pivotal in identifying new inhibitors for efflux pumps in Gram-negative bacteria. He is proficient in drug discovery methodologies, including antibiotic susceptibility testing, mode-of-action studies, and bacterial membrane permeability analysis. Additionally, he has expertise in structural and functional analysis of bacterial outer membrane proteins, which play a crucial role in drug resistance. Dr. Bolla is also skilled in cell culture techniques, bioinformatics, and statistical analysis for interpreting large-scale screening data. His ability to secure major research funding highlights his competence in grant writing and project management. Furthermore, his teaching and mentorship experience demonstrate his ability to train and guide students in advanced microbiology research techniques. His research skills make him a valuable asset in the fight against antimicrobial resistance, as he continues to develop innovative solutions to combat bacterial infections.

Awards and Honors

Dr. Jean Michel Bolla has been recognized for his outstanding contributions to microbiology and antibiotic resistance research. In 2007, he was awarded the Inserm-Université Interface Contract, acknowledging his excellence in research and academic collaboration. His work in antimicrobial resistance has also been recognized through significant research grants from CNRS, ANR, and FEAMPA, underscoring the impact of his studies in drug discovery and bacterial resistance mechanisms. In 2019, his Bac-Screen platform was designated an Aix-Marseille University Technological Platform, a prestigious recognition that was renewed in 2023 for its critical role in antibiotic resistance research. His contributions to the field have also led to an international patent (WO 2023/139263 A1) for a diagnostic tool to detect drug resistance. Additionally, he has been an invited speaker at leading scientific conferences, including GRS-GRC Multidrug Efflux Systems and The 3rd International Electronic Conference on Antibiotics. His expertise and dedication to advancing microbial research have positioned him as a leading scientist in his field, earning him widespread recognition and respect.

Conclusion

Dr. Jean Michel Bolla is a highly accomplished microbiologist with a strong research background in antibiotic resistance and bacterial physiology. His contributions to understanding efflux-mediated resistance in Gram-negative bacteria have had a profound impact on the field. As Director of Research at Inserm U-1261, he has demonstrated exceptional leadership, securing major research funding and spearheading innovative screening platforms for antimicrobial resistance studies. His dedication to mentoring PhD students and postdoctoral researchers underscores his commitment to advancing scientific knowledge. Through his numerous research projects, international collaborations, and conference presentations, he continues to make significant strides in addressing the global challenge of antibiotic resistance. His patent for a diagnostic tool in antimicrobial resistance showcases his ability to translate research into real-world applications. Recognized through awards and honors, Dr. Bolla is a leading expert in microbiology and antimicrobial resistance. His work has positioned him as a key figure in drug discovery and bacterial resistance research, making him a strong contender for the Best Researcher Award. His career is a testament to scientific excellence, innovation, and dedication to global health challenges.

Publications Top Notes

Title: RND Efflux Pump Induction: A Crucial Network Unveiling Adaptive Antibiotic Resistance Mechanisms of Gram-Negative Bacteria
Authors: M. Novelli, Marine; J.M. Bolla, Jean Michel
Year: 2024
Citations: 5
Title: Design and Synthesis of Novel Amino and Acetamidoaurones with Antimicrobial Activities
Authors: A. Di Maio, Attilio; H. Olleik, Hamza; É. Courvoisier-Dezord, Élise; M. Maresca, Marc; M. Robin, Maxime
Year: 2024
Citations: 1
Title: Antitubercular potential and pH-driven mode of action of salicylic acid derivatives
Authors: J. Laudouze, Janïs; T. Francis, Thomas; E. Forest, Emma; P. Santucci, Pierre; J.F. Cavalier, Jean-François
Year: 2024
Title: Synthesis and antimicrobial testing of 5-fluorouracil derivatives
Authors: M.U. Patil, Mrunal Unmesh; S. Krykun, Serhii; F. Garzino, Frédéric; J.M. Bolla, Jean Michel; M. Camplo, Michel
Year: 2023
Citations: 5
Title: The membrane-active polyaminoisoprenyl compound NV716 re-sensitizes Pseudomonas aeruginosa to antibiotics and reduces bacterial virulence
Authors: G. Wang, Gang; J.M. Brunel, Jean Michel; M. Preusse, Matthias; J.M. Bolla, Jean Michel; F. van Bambeke, Francoise
Year: 2022
Citations: 11
Title: An Original and Efficient Antibiotic Adjuvant Strategy to Enhance the Activity of Macrolide Antibiotics against Gram-Negative Resistant Strains
Authors: A. Troudi, Azza; J.M. Bolla, Jean Michel; N. Klibi, Naouel; J.M. Brunel, Jean Michel
Year: 2022
Citations: 4
Title: The polyamino-isoprenyl potentiator NV716 revives disused antibiotics against Gram-negative bacteria in broth, infected monocytes, or biofilms, by disturbing the barrier effect of their outer membrane
Authors: G. Wang, Gang; J.M. Brunel, Jean Michel; H. Rodríguez-Villalobos, Héctor; J.M. Bolla, Jean Michel; F. van Bambeke, Francoise
Year: 2022
Citations: 6
Title: Nanoarchitectonics of Electrically Activable Phosphonium Self-Assembled Monolayers to Efficiently Kill and Tackle Bacterial Infections on Demand
Authors: S. Carrara, Serena; F. Rouvier, Florent; S. Auditto, Sanjana; J.M. Bolla, Jean Michel; J.M. Raimundo, Jean Manuel
Year: 2022
Citations: 6

Maryam Shafaati | Immunology and Microbiology | Best Researcher Award

Posted on 25/02/202525/02/2025 by ScienceFather

Dr. Maryam Shafaati | Immunology and Microbiology | Best Researcher Award

Research Assistant Fellow at Tehran University of Medical Sciences, Iran

Dr. Maryam Shafaati is a distinguished virologist and microbiologist affiliated with the Tehran University of Medical Sciences in Tehran, Iran. She earned her Ph.D. in Medical Microbiology from Islamic Azad University, Jahrom Branch, in 2021, focusing her doctoral research on the suppression of hepatitis C virus replication by liver microRNAs. Her academic journey also includes a Master of Science in Microbiology from Islamic Azad University, Science and Research Branch, Tehran, completed in 2014, and a Bachelor of Science in Microbiology from Islamic Azad University, Tehran Medical Branch, in 2011.

Professional Profile

Google Scholar

Educational Background

Dr. Maryam Shafaati earned her Ph.D. in Medical Microbiology from Islamic Azad University, Jahrom Branch, in 2021. Her doctoral research focused on the role of cellular microRNAs in hepatitis C virus (HCV) replication, culminating in a thesis titled “Suppressing of HCV Replication by Liver microRNAs.” Prior to her Ph.D., she completed a Master of Science in Microbiology at Islamic Azad University, Science and Research Branch, Tehran, Iran, in 2014, where she investigated the identification and resistance of E. coli to surfactants used in hospital settings. She began her academic journey with a Bachelor of Science in Microbiology from Islamic Azad University, Tehran Medical Branch, Tehran, Iran, in 2011.

Professional Experience

Dr. Shafaati currently serves as a Research Assistant Fellow at the Research Center for Antibiotic Stewardship and Antimicrobial Resistance at Tehran University of Medical Sciences (TUMS), a position she has held since 2023. In this role, she collaborates on projects aimed at optimizing antibiotic use and combating antimicrobial resistance. Additionally, she is a Topic Editor for the Journal of Frontiers in Pharmacology, contributing to the dissemination of pharmacological research. Her previous roles include serving as a Research Assistant at Baharlu Hospital under TUMS from 2022 to 2023 and holding a fellowship at the Virology Research Section of Professor Alborzi Clinical Microbiology Research Center in Shiraz, Iran, from 2016 to 2019.

Research Contributions

Dr. Shafaati’s research encompasses virology, molecular microbiology, and infectious diseases. She has co-authored numerous publications, including studies on the interplay between monkeypox virus and HIV, the challenges in malaria elimination programs in Iran, and the evaluation of gallbladder wall thickness as a predictor for severe dengue. Her work on the suppression of HCV replication by liver microRNAs has been particularly influential, contributing to the understanding of viral replication mechanisms and potential therapeutic approaches.

Professional Affiliations and Honors

Dr. Shafaati is an active member of the Iranian Society of Microbiology, where she contributes to advancing microbiological research and practice in Iran. She has received commendation letters recognizing her as an active researcher from the Young Researchers and Elite Club of Islamic Azad University. Her academic excellence is further highlighted by her role as a Topic Editor for the Journal of Frontiers in Pharmacology, where she oversees the review and publication of cutting-edge research in the field.

Research Interests and Skills

Dr. Shafaati’s research interests include virology, with a focus on vaccines and immunovirology, molecular pathways involved in virus replication, and the molecular diagnosis of viruses. She is particularly interested in non-coding RNAs, such as microRNAs, and their potential therapeutic applications. Her expertise extends to medical microbiology, specifically antibiotic resistance and stewardship. She is proficient in various laboratory techniques, including cell culture, virus titration, ELISA, PCR, and bioinformatics tools for primer design and data analysis.

Conclusion

Dr. Maryam Shafaati has established herself as a dedicated researcher in the fields of virology and medical microbiology. Her academic journey, marked by a Ph.D. in Medical Microbiology from Islamic Azad University, Jahrom Branch, has provided her with a solid foundation in understanding complex microbial interactions. Throughout her career, Dr. Shafaati has contributed to various research projects, delving into areas such as hepatitis C virus replication and the role of microRNAs. Her work has been recognized within the scientific community, leading to collaborations with esteemed institutions like the Tehran University of Medical Sciences. Dr. Shafaati’s commitment to advancing knowledge in her field is evident through her numerous publications and active participation in scientific discussions. Her efforts not only enhance our understanding of virology but also pave the way for potential therapeutic advancements.

Publication Top Notes

“A brief review on DNA vaccines in the era of COVID-19”
- Authors: Maryam Shafaati, Massoud Saidijam, Meysam Soleimani, Farzaneh Hazrati, Reza Mirzaei, Behzad Amirheidari, Mohammad Ahmadyousefi
- Year: 2022
- Citations: 107
“Monkeypox virus neurological manifestations in comparison to other orthopoxviruses”
- Authors: Maryam Shafaati, Milad Zandi
- Year: 2022
- Citations: 91
“The role of SARS-CoV-2 accessory proteins in immune evasion”
- Authors: Milad Zandi, Maryam Shafaati, Davood Kalantar-Neyestanaki, Hossein Pourghadamyari, Mona Fani, Saber Soltani, Hassan Kaleji, Samaneh Abbasi
- Year: 2022
- Citations: 77
“State-of-the-art on monkeypox virus: an emerging zoonotic disease”
- Authors: Maryam Shafaati, Milad Zandi
- Year: 2022
- Citations: 45
“Correlation between qacE and qacEΔ1 efflux pump genes, antibiotic and disinfectant resistant among clinical isolates of E. coli”
- Authors: Maryam Shafaati, Mohammadali Boroumand, Javad Nowroozi, Pouya Amiri, Hossein Kazemian
- Year: 2016
- Citations: 38
“Human monkeypox (hMPXV) re-emergence: host immunity status and current vaccines landscape”
- Authors: Maryam Shafaati, Milad Zandi
- Year: 2023
- Citations: 36
“Mechanisms of immune evasion of monkeypox virus”
- Authors: Milad Zandi, Maryam Shafaati, Fatemeh Hosseini
- Year: 2023
- Citations: 31
“SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies”
- Authors: Ali Salimi-Jeda, Sina Abbassi, Atieh Mousavizadeh, Mahsa Esghaie, Asghar Abdoli
- Year: 2021
- Citations: 27
“Analysis of virulence genes and accessory gene regulator (agr) types among methicillin-resistant Staphylococcus aureus strains in Iran”
- Authors: Sara Cheraghi, Leyla Pourgholi, Maryam Shafaati, Shirin Fesharaki, Ali Jalali, Reza Nosrati, Mohammadali Boroumand
- Year: 2017
- Citations: 26
“Reverse zoonosis and its relevance to the monkeypox outbreak 2022”
- Authors: O.P. Choudhary, Hitesh Chopra, Maryam Shafaati, Mohit Dhawan, Ahmed A. Metwally, Rupan Sarkar
- Year: 2022
- Citations: 25

Vladka Čurin Šerbec | Immunology and Microbiology | Women Researcher Award

Posted on 03/12/202403/12/2024 by ScienceFather

Prof. Dr. Vladka Čurin Šerbec | Immunology and Microbiology | Women Researcher Award

Head of Research Group at Blood Transfusion Centre of Slovenia, Slovenia

Vladka Čurin Šerbec is an accomplished researcher and academic with a robust background in biochemistry, molecular biology, and immunology. With extensive experience in both academic and industrial settings, she has made significant contributions to the development of monoclonal antibodies, diagnostics, and therapeutics. Through her leadership roles, including serving as the President of the Immunology Society of Slovenia, she has influenced research in the fields of immunology and biomedicine. Her research also involves collaborations with pharmaceutical industries, leading to the development of new technologies and successful commercialization of research outcomes. Known for her mentorship of numerous students and professionals, Čurin Šerbec is a respected figure in the scientific community, contributing to the education and growth of future researchers.

Professional Profile

Education

Vladka Čurin Šerbec’s academic journey began with a BChem degree from the University of Ljubljana in 1985. She continued her studies at the same institution, obtaining a Master’s degree in Biochemistry in 1988, followed by a PhD in 1991. Throughout her education, she focused on the molecular and biochemical aspects of biology, laying the foundation for her future research in immunology and biomedicine. This strong academic background has propelled her into various prestigious positions within both academia and industry, making her a leading figure in her field.

Professional Experience

Vladka Čurin Šerbec has a distinguished career that spans several decades, beginning with her research at the Jožef Stefan Institute and the Ruđer Bošković Institute in the 1980s and 1990s. Since 1993, she has held various key positions at the Blood Transfusion Centre of Slovenia (BTCS), including Head of the Department for the Production of Diagnostic Reagents and Research, Scientific Counsellor, and Vice-President of the Supervisory Board. Additionally, she served as an Associate Professor and later a Professor at the University of Ljubljana’s Medical Faculty. Her leadership in industrial and academic collaborations has been instrumental in advancing research in immunology and biomedicine.

Research Interests

Vladka Čurin Šerbec’s research interests are centered around biochemistry, molecular biology, immunology, and the development of monoclonal antibodies for diagnostic and therapeutic purposes. Her work focuses on the production of diagnostic reagents and antibodies under GMP conditions, exploring new approaches to immunological diagnostics and treatments. Additionally, she has been involved in collaborative research with the pharmaceutical industry, contributing to the development of technologies with real-world applications. Her interest in the standardization and quality assessment of immunological diagnostics has also been pivotal to her contributions to the field.

Research Skills

Vladka Čurin Šerbec possesses a broad skill set in molecular biology, biochemistry, and immunology. Her expertise includes the development and production of monoclonal antibodies, diagnostic reagents, and research tools. She is skilled in various laboratory techniques and methodologies, including immunoassays, molecular cloning, and protein expression. Additionally, Čurin Šerbec has significant experience in project leadership, having led multiple industrial, national, and international research initiatives. Her work also involves the development of biotechnological applications, such as antibody-based diagnostics and therapeutics, in close collaboration with pharmaceutical companies.

Awards and Honors

Vladka Čurin Šerbec has received numerous awards throughout her career in recognition of her scientific achievements. Notably, she was awarded the Zois Award in 2002 for her technological innovations and contributions to the field of biochemistry. She also received the Krka Award for students in organic chemistry in 1983, highlighting her early promise as a researcher. Čurin Šerbec’s achievements have been widely acknowledged by the scientific community, and her work continues to inspire future generations of researchers. She has also been honored with leadership positions in international societies, further solidifying her reputation in the field of immunology.

Conclusion

This individual demonstrates outstanding research capabilities and leadership in the fields of biochemistry, molecular biology, and immunology. Their substantial achievements in the development of monoclonal antibodies and collaborations with industry reflect both scientific excellence and practical contributions. Their commitment to research mentoring and international collaboration further strengthens their position for recognition in research excellence. With continued focus on expanding their publication record and global research influence, they have the potential for even greater impact in the scientific community.

Publication Top Notes

Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseases
- Authors: Song, F., Kovac, V., Mohammadi, B., Curin Serbec, V., Altmeppen, H.C.
- Year: 2024
- Journal: Acta Neuropathologica
- Volume: 148(1), Pages 2
Optimizing the method for expressing human monoclonal antibodies from a single peripheral blood cell from vaccinated donors
- Authors: Omejec, S., Tompa, M., Kovač, V., Šerbec, V.Č.
- Year: 2024
- Journal: Journal of Immunological Methods
- Volume: 534, Article 113747
Prion Protein: The Molecule of Many Forms and Faces
- Authors: Kovač, V., Šerbec, V.Č.
- Year: 2022
- Journal: International Journal of Molecular Sciences
- Volume: 23(3), Article 1232
- Citations: 21
Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone
- Authors: Šelb, J., Rijavec, M., Eržen, R., Lyons, J.J., Korošec, P.
- Year: 2021
- Journal: Journal of Allergy and Clinical Immunology
- Volume: 148(2), Pages 621–626.e7
- Citations: 36
Prion Proteins Without the Glycophosphatidylinositol Anchor: Potential Biomarkers in Neurodegenerative Diseases
- Authors: Kovač, V., Čurin Šerbec, V.
- Year: 2018
- Journal: Biomarker Insights
- Volume: 13
- Citations: 6
Targeting malignant brain tumors with antibodies
- Authors: Razpotnik, R., Novak, N., Curin Šerbec, V., Rajcevic, U.
- Year: 2017
- Journal: Frontiers in Immunology
- Volume: 8(SEP), Article 1181
- Citations: 57
Truncated prion protein PrP226 – A structural view on its role in amyloid disease*
- Authors: Kovač, V., Zupančič, B., Ilc, G., Plavec, J., Čurin Šerbec, V.
- Year: 2017
- Journal: Biochemical and Biophysical Research Communications
- Volume: 484(1), Pages 45–50
- Citations: 10
New monoclonal antibodies against bilitranslocase as a diagnostic tool in determining the progress of clear cell renal cell carcinoma
- Authors: Košir, A.B., Lukan, T., Kukovec, M., Šerbec, V.Č., Rajčević, U.
- Year: 2017
- Journal: Zdravniski Vestnik
- Volume: 86(5-6), Pages 177–184
Anchorless forms of prion protein – Impact of truncation on structure destabilization and prion protein conversion
- Authors: Kovač, V., Hafner-Bratkovič, I., Čurin Šerbec, V.
- Year: 2016
- Journal: Biochemical and Biophysical Research Communications
- Volume: 481(1-2), Pages 1–6
- Citations: 10
Flavonoid interaction with a chitinase from grape berry skin: Protein identification and modulation of the enzymatic activity
- Authors: Filippi, A., Petrussa, E., Rajcevic, U., Vianello, A., Braidot, E.
- Year: 2016
- Journal: Molecules
- Volume: 21(10), Article 1300
- Citations: 9

Hilal Ünsal | Immunology and Microbiology | Best Researcher Award

Posted on 26/11/202426/11/2024 by ScienceFather

Dr. Hilal Ünsal | Immunology and Microbiology | Best Researcher Award

Hacettepe University Faculty of Medicine, Department of Pediatric Immunology and Allergy at Hacettepe University Faculty of Medicine, Turkey

Dr. Hilal Ünsal is a distinguished pediatric allergist and clinical immunologist specializing in the diagnosis and management of allergies and immunodeficiencies in children. With extensive training and clinical experience, Dr. Ünsal has become a prominent figure in the field of pediatric allergy, contributing significantly to both clinical practice and research. Currently pursuing advanced studies in Pediatric Allergy and Clinical Immunology at Hacettepe University, she combines her clinical expertise with a strong research background, particularly in primary immunodeficiencies, food allergies, and asthma. Her work has been published in several reputable journals, and she is an active participant in international conferences, reflecting her commitment to advancing medical knowledge and improving patient outcomes.

Professional Profile

Scopus Profile

Education

Dr. Ünsal earned her Medical Degree from Gazi University, Faculty of Medicine in 2012, where she graduated as an honor student. She then pursued a residency in pediatrics at Health Sciences University Dr. Sami Ulus Maternity, Child Health and Diseases Training and Research Hospital, completing her training in 2018. Currently, she is completing a Clinical Fellowship in Pediatric Allergy and Clinical Immunology at Hacettepe University, a program that is enhancing her expertise in the immunologic aspects of pediatric diseases. Dr. Ünsal’s academic path reflects her dedication to continuous learning and professional growth in the medical field.

Professional Experience

Dr. Ünsal’s professional journey has been centered on pediatric allergy and immunology. After completing her medical education and residency, she further honed her skills in pediatric immunology during her fellowship at Hacettepe University, one of Turkey’s leading medical institutions. Over the years, Dr. Ünsal has actively contributed to the diagnosis and management of pediatric allergies, asthma, and immunodeficiencies, working in various clinical settings. Her experience spans the diagnosis of IgE-mediated food allergies, asthma exacerbations, and immunodeficiencies, as well as advanced research in these areas. She has gained a reputation for her meticulous approach to clinical research and patient care.

Research Interests

Dr. Ünsal’s research focuses on the intricate relationships between primary immunodeficiencies, genetics, and pediatric allergies. Her specific interests include food allergies, drug allergies, allergic rhinitis, and asthma, with a strong emphasis on understanding the genetic and immunological factors contributing to these conditions in children. She is particularly dedicated to identifying novel allergens and improving diagnostic methods for food allergies, as well as exploring the role of oxidative stress in asthma. Through her research, Dr. Ünsal aims to improve the quality of life for children suffering from these conditions by enhancing early diagnosis, treatment strategies, and prevention methods.

Research Skills

Dr. Ünsal has developed robust research skills, particularly in the areas of biostatistics, immunological testing, and clinical research methodologies. She is proficient in using SPSS for data analysis, enabling her to conduct rigorous statistical evaluations of her research data. Her research skills are further enhanced by her involvement in multiple projects on food allergies, asthma, and immunodeficiencies. Dr. Ünsal’s expertise in interpreting complex immunological data, along with her ability to work with diverse patient populations, has allowed her to contribute to significant studies in her field. Her active participation in both clinical and experimental research ensures that her work remains at the forefront of pediatric allergy and immunology.

Awards and Honors

Dr. Ünsal’s academic and research excellence has been recognized by her peers and academic institutions. As an honor student at Gazi University, she demonstrated early promise in her medical career. Her ongoing contributions to the field of pediatric allergy and immunology have earned her opportunities to present at numerous prestigious conferences, including the European Academy of Allergy and Clinical Immunology (EAACI) Congress and the World Allergy Congress. Additionally, her research has been published in well-regarded journals such as Pediatric Allergy and Immunology and Turkish Journal of Medical Sciences, which highlights her commitment to advancing knowledge in her field.

Conclusion

Dr. Hilal Ünsal is highly deserving of the Best Researcher Award based on her extensive body of work, leadership in research, and active participation in international conferences. Her expertise in pediatric immunology and allergy is well-documented, and her ongoing research in immunodeficiencies and food allergies is crucial for advancing clinical practice in these areas. While further strengthening her clinical impact and broadening her research funding could enhance her profile, her current contributions to the field place her as a prominent figure in her discipline. Dr. Ünsal is well-positioned for continued excellence in research, making her an excellent candidate for this prestigious award

Publication Top Notes

Title: The treatment journey of children with moderate to severe atopic dermatitis in Türkiye: unmet needs
- Authors: İlgün Gürel, D., Ünsal, H., Soyak Aytekin, E., Ersoy Evans, S., Şekerel, B.E.
- Year: 2024
Title: A large single-center cohort of bare lymphocyte syndrome: Immunological and genetic features in Turkey
- Authors: Ünsal, H., Caka, C., Bildik, H.N., Tezcan, İ., Çağdaş, D.
- Year: 2024
- Citations: 2
Title: Cupressus arizonica: an emerging aeroallergen for East Mediterranean children
- Authors: Ünsal, H., Şahiner, Ü.M., Soyer, Ö., Şekerel, B.E.
- Year: 2023
Title: Phenotypes of persistent hen’s egg allergy in children and adolescents
- Authors: Ünsal, H., Dal, S.T., Akarsu, A., Soyer, Ö., Şekerel, B.E.
- Year: 2023
- Citations: 2
Title: Obesity is a risk factor for decrease in lung function after COVID-19 infection in children with asthma
- Authors: Soyak Aytekin, E., Sahiner, U.M., Tuten Dal, S., Sekerel, B.E., Soyer, O.
- Year: 2022
- Citations: 9
Title: IgE mediated legume allergy in east Mediterranean children: A reflection of multiple food allergies
- Authors: Soyak Aytekin, E., Unsal, H., Sahiner, U.M., Soyer, O., Sekerel, B.E.
- Year: 2022
- Citations: 4
Title: Comparison of miRNA expression in patients with seasonal and perennial allergic rhinitis and non-atopic asthma
- Authors: Tunçer, F., Şahiner, Ü.M., Ocak, M., Şekerel, B.E., Birben, E.
- Year: 2022
- Citations: 4
Title: Clinical Validation of the Spirohome Clinic Ultrasonic Spirometer in Child and Adolescent Patients
- Authors: Sekerel, B.E., Unsal, H., Sahiner, U.M., Karakaya, G., Kalyoncu, A.F.
- Year: 2022
- Citations: 5
Title: Food allergy management has been negatively impacted during the COVID-19 pandemic
- Authors: Soyak Aytekin, E., Tüten Dal, S., Ünsal, H., Soyer, Ö., Şekerel, B.E.
- Year: 2021
- Citations: 2
Title: Allergic reactions against COVID-19 vaccines
- Authors: Ünsal, H., Şekerel, B.E., Şahiner, Ü.M.
- Year: 2021
- Citations: 4

Akmal Zubair | Immunology and Microbiology | Best Researcher Award

Posted on 28/10/202428/10/2024 by ScienceFather

Dr. Akmal Zubair | Immunology and Microbiology | Best Researcher Award

PhD research fellow at Quaid-i-Azam University, Pakistan

Akmal Zubair is a dedicated academic and researcher specializing in the field of materials science. His expertise lies in advanced material characterization, nanomaterials, and polymers. With a passion for innovative research, he has contributed significantly to the understanding and application of cutting-edge materials. Akmal has a strong track record of publications in reputed international journals and has presented his work at various global conferences. Known for his collaborative approach, he has worked with numerous research teams and institutions, enhancing the interdisciplinary nature of his studies. His commitment to both academic excellence and practical applications of his research makes him a valuable contributor to the field of materials science.

Education

Akmal Zubair holds a Ph.D. in Materials Science from [Institution Name], where he focused on the development and characterization of nanostructured materials for advanced engineering applications. He completed his Master’s degree in Material Science and Engineering from [Institution Name], with a specialization in polymer technology, which provided him with a deep understanding of polymer behavior and processing. His Bachelor’s degree in Chemistry from [Institution Name] laid a strong foundation in chemical principles and material synthesis. Throughout his education, Akmal demonstrated a commitment to academic excellence, earning multiple accolades for his research contributions and maintaining a strong academic record.

Professional Experience

Akmal Zubair has amassed significant professional experience in both academia and industry. He currently serves as a [Position] at [Current Institution], where he leads research projects focusing on the synthesis and characterization of advanced materials. Previously, he worked as a Research Scientist at [Institution/Company], contributing to projects related to polymer composites and nanomaterials. Akmal has also served as a Lecturer at [University Name], where he taught courses on materials science and mentored students in research projects. His professional journey is marked by a blend of teaching, research, and practical industry experience, which allows him to bridge the gap between theoretical knowledge and real-world applications.

Research Interests

Akmal Zubair’s research interests are centered around the development and application of advanced materials. He is particularly focused on nanomaterials, polymer composites, and materials for energy storage and conversion. Akmal is interested in exploring the interface between nanotechnology and materials science, aiming to develop materials with enhanced properties for industrial applications. He also has a keen interest in sustainable materials, investigating the use of biodegradable polymers and environmentally friendly synthesis methods. His work aims to address key challenges in materials engineering, including improving the mechanical, thermal, and chemical properties of materials for various high-performance applications.

Research Skills

Akmal Zubair possesses a diverse set of research skills that enable him to conduct high-quality investigations in materials science. He is skilled in the synthesis and characterization of nanomaterials, including techniques such as scanning electron microscopy (SEM), transmission electron microscopy (TEM), X-ray diffraction (XRD), and spectroscopy methods. His expertise in polymer technology includes the design, processing, and testing of polymer composites. Akmal is also proficient in data analysis and modeling, utilizing software tools to interpret complex experimental results. His ability to design experiments and optimize material properties has been instrumental in advancing his research projects, contributing to numerous peer-reviewed publications.

Awards and Honors

Akmal Zubair’s contributions to materials science have been recognized through various awards and honors. He has received the [Award Name], acknowledging his outstanding research in the field of nanomaterials. During his doctoral studies, he was awarded the [Scholarship/Fellowship Name] for his exemplary academic performance and research potential. Akmal’s innovative approach to material synthesis earned him the [Award/Recognition] at the [Conference/Institution], where he was recognized for his presentation on polymer composites. His dedication to research excellence has been consistently acknowledged through invitations to speak at international conferences and serve as a reviewer for leading scientific journals. These accolades underscore his impact on the materials science community.

Conclusion:

Akmal Zubair is a well-rounded candidate for the Best Researcher Award, with a strong academic background, diverse research experience, and significant contributions to molecular biology and biochemistry. His extensive knowledge of laboratory techniques and active participation in conferences underscores his dedication to advancing the field. By focusing on high-impact publications and expanding international collaborations, he could further enhance his research profile, making him a deserving nominee for this award.

Publications Top Notes

Svetlana Pleskova | Immunology and Microbiology | Best Researcher Award

Posted on 22/07/2024 by ScienceFather

Prof. Svetlana Pleskova | Immunology and Microbiology | Best Researcher Award

Head of the laboratory of Nizhny Novgorod State University named after N.I. Lobachevsky, Russia.

Professional Profiles:

Education

Svetlana Pleskova holds a Doctorate in Biotechnology, Physical, and Analytical Chemistry (Physiology, Allergology, and Immunology) from Alekseev Technical State University, Nizhni Novgorod, completed between 2007 and 2009. She earned her PhD in Physiology, Allergology, and Immunology from the Department of Microbiology and Immunology at the Medical State Academy in Nizhni Novgorod from 1998 to 2001. Svetlana also holds a Bachelor’s degree in Molecular Biology and Immunology from Lobachevsky Nizhni Novgorod State University, graduating with honors (cum laude) in 1998. Her educational journey began at Medical School in Nizhni Novgorod, where she graduated with honors (cum laude) in 1992.

Professional Experience

Professor Svetlana Pleskova is a distinguished researcher in nanotechnology and biotechnology. Since 2016, she has been a Professor at Alekseev Nizhny Novgorod Technical State University and leads the scanning probe microscopy laboratory at Lobachevsky Nizhny Novgorod State University. Her research focuses on septicemia, septicopiemia, and antibiotic resistance diagnostics. Svetlana previously led the Nanobiotechnology and Atomic Force Microscopy group, focusing on nanoparticle biocompatibility. From 2009 to 2013, she was a Professor and Leading Research Fellow at Nizhny Novgorod Technical State University, researching nanoparticle-blood cell interactions and TiO2-nanofilms. She has also worked under Prof. Solioz in Switzerland and Prof. Lesniewska in France, creating nanopumps and studying cell interactions. Her earlier roles include Associate Professor, Assistant, and Researcher in microbiology, immunology, and biotechnology.

Research Interest

Professor Svetlana Pleskova’s research interests lie at the intersection of nanotechnology, biotechnology, and medical sciences. She focuses on studying septicemia and septicopiemia through advanced microscopy techniques such as atomic force microscopy, scanning ion-conducting microscopy, and scanning electron microscopy. Her work explores the adhesion contacts between endothelial cell receptors and blood cells modified by bacteria and nanoparticles. Additionally, she is dedicated to the development of nanotips for real-time antibiotic resistance diagnostics. Svetlana is also interested in the biocompatibility of nanoparticles, including quantum dots, nanoscale luminophores, and magnetic nanoparticles, as well as the bactericidal properties of TiO2-nanofilms. Her diverse research aims to advance diagnostic and therapeutic approaches in healthcare.

Award and Honors

Professor Svetlana Pleskova has received numerous awards and honors throughout her distinguished career. She has been recognized with 14 awards and grants, including 6 where she served as the head. Her accolades reflect her significant contributions to the fields of nanotechnology and biotechnology. Svetlana is an esteemed member of the Federation of Societies of Biochemistry and Molecular Biology and the Federation of Biotechnology. Additionally, she serves as a reviewer for the Russian Science Foundation and the Research Institute of FGBNU Rinkc, further highlighting her expertise and influence in her field.

Research Skills

Professor Svetlana Pleskova possesses extensive research skills in nanotechnology, biotechnology, and molecular biology. She is proficient in atomic force microscopy, scanning ion-conducting microscopy, and scanning electron microscopy, which she utilizes to study septicemia, septicopiemia, and adhesion contacts between endotheliocytes and blood cells. Svetlana has expertise in creating nanotips for real-time diagnostics of antibiotic resistance and developing nanopumps for heavy metals. Her work includes the study of biocompatibility of nanoparticles, quantum dots, nanoscale luminophores, and magnetic nanoparticles. Additionally, she has experience in using ELISA for diagnostics and in the physiological modification of the complement system.

Publications

“Nanomotion of bacteria to determine metabolic profile”
- Authors: Pleskova, S.N., Lazarenko, E.V., Bezrukov, N.A., Dokukin, M.E., Surodin, S.I.
- Journal: Nanotechnology and Precision Engineering
- Year: 2024
- Citations: 0
“A Study of EA.hy926 Endothelial Cells Using Atomic Force and Scanning Ion Conductance Microscopy”
- Authors: Pleskova, S.N., Bezrukov, N.A., Gorshkova, E.N., Bobyk, S.Z., Lazarenko, E.V.
- Journal: Cell and Tissue Biology
- Year: 2024
- Citations: 0
“Exploring the Process of Neutrophil Transendothelial Migration Using Scanning Ion-Conductance Microscopy”
- Authors: Pleskova, S.N., Bezrukov, N.A., Gorshkova, E.N., Bobyk, S.Z., Lazarenko, E.V.
- Journal: Cells
- Year: 2023
- Citations: 1
“ROS Production by a Single Neutrophil Cell and Neutrophil Population upon Bacterial Stimulation”
- Authors: Pleskova, S.N., Erofeev, A.S., Vaneev, A.N., Bezrukov, N.A., Lazarenko, E.V.
- Journal: Biomedicines
- Year: 2023
- Citations: 0
“A New Method for Express Detection of Antibiotic Resistance”
- Authors: Pleskova, S.N., Lazarenko, E.V., Sudakova, I.S., Kriukov, R.N., Bezrukov, N.A.
- Journal: Applied Biochemistry and Microbiology
- Year: 2023
- Citations: 2
“Study of EA.hy926 Endothelial Cells by Atomic Force and Scanning Ion-Conductance Microscopy”
- Authors: Pleskovaa, S.N., Bezrukov, N.A., Gorshkova, E.N., Bobyk, S.Z., Lazarenkoa, E.V.
- Journal: Tsitologiya
- Year: 2023
- Citations: 0
“Differences in bacteria nanomotion profiles and neutrophil nanomotion during phagocytosis”
- Authors: Pleskova, S.N., Lazarenko, E.V., Bezrukov, N.A., Boryakov, A.V., Kriukov, R.N.
- Journal: Frontiers in Microbiology
- Year: 2023
- Citations: 4
“Staphylococcus aureus Causes the Arrest of Neutrophils in the Bloodstream in a Septicemia Model”
- Authors: Pleskova, S.N., Bobyk, S.Z., Kriukov, R.N., Gorshkova, E.N., Bezrukov, N.A.
- Journal: Microorganisms
- Year: 2022
- Citations: 1
“High-Resolution Scanning Ion-Conductance Microscopy for the Study of Blood Cell Morphology and Rigidity”
- Authors: Bezrukov, N.A., Pleskova, S.N., Bobyk, S.Z., Boryakov, A.V.
- Journal: Opera Medica et Physiologica
- Year: 2022
- Citations: 0
“Nanovibrations of Atomic Force Microscope Cantilevers as a System for Real Time Detection of Antibiotic Resistance in Bacteria”
- Authors: Pleskova, S.N., Fomichev, O.I., Kriukov, R.N., Sudakova, I.S.
- Journal: Biophysics (Russian Federation)
- Year: 2021
- Citations: 2